Abstract
A number of benzimidazole compounds namely, N-(4-(1H-benzimidazol-2-yl)phenyl)-4-(1H-benzimidazol-2- yl)-benzamide derivatives (8-10) and N-(3- or 4-(1H-benzimidazol-2-yl)phenyl)-2-phenyl-1H-benzimidazole-5- carboxamide derivatives (18-21) were synthesized and antibacterial and antioxidant activities were evaluated. Antibacterial activities of 9, 10, 18, and 20 against MRSA-isolate are equal to ampicillin. Compounds 18, 19, and 21 displayed better antifungal activities against Candida albicans. Antioxidant properties were evaluated by several methods, such as inhibition of lipid peroxidation, superoxide anion production, and DPPH stable free radical, and also their effects on hepatic cytochrome P450 (CYP) dependent ethoxyresorufin O-deethylase (EROD) enzyme were determined in rats in vitro. Compounds 18 and 20 had strong scavenger effect on superoxide anion (90%, and 99%, respectively) at 10-3 M concentration. Compound 19 showed significant inhibition on EROD activity with 98%, which is better than that of caffeine being a specific inhibitor of EROD activity (85%).
Keywords: Benzimidazole, Synthesis, Antimicrobial, Antioxidant
Letters in Drug Design & Discovery
Title: Synthesis, Antimicrobial and Antioxidant Activities of Some Benzimidazole Derivatives
Volume: 6 Issue: 5
Author(s): Canan Kus, Gulgun Ayhan-K1lc1gil, Meral Tuncbilek, Nurten Altanlar, Tulay Coban, Benay Can-Eke and Mumtaz Iscan
Affiliation:
Keywords: Benzimidazole, Synthesis, Antimicrobial, Antioxidant
Abstract: A number of benzimidazole compounds namely, N-(4-(1H-benzimidazol-2-yl)phenyl)-4-(1H-benzimidazol-2- yl)-benzamide derivatives (8-10) and N-(3- or 4-(1H-benzimidazol-2-yl)phenyl)-2-phenyl-1H-benzimidazole-5- carboxamide derivatives (18-21) were synthesized and antibacterial and antioxidant activities were evaluated. Antibacterial activities of 9, 10, 18, and 20 against MRSA-isolate are equal to ampicillin. Compounds 18, 19, and 21 displayed better antifungal activities against Candida albicans. Antioxidant properties were evaluated by several methods, such as inhibition of lipid peroxidation, superoxide anion production, and DPPH stable free radical, and also their effects on hepatic cytochrome P450 (CYP) dependent ethoxyresorufin O-deethylase (EROD) enzyme were determined in rats in vitro. Compounds 18 and 20 had strong scavenger effect on superoxide anion (90%, and 99%, respectively) at 10-3 M concentration. Compound 19 showed significant inhibition on EROD activity with 98%, which is better than that of caffeine being a specific inhibitor of EROD activity (85%).
Export Options
About this article
Cite this article as:
Kus Canan, Ayhan-K1lc1gil Gulgun, Tuncbilek Meral, Altanlar Nurten, Coban Tulay, Can-Eke Benay and Iscan Mumtaz, Synthesis, Antimicrobial and Antioxidant Activities of Some Benzimidazole Derivatives, Letters in Drug Design & Discovery 2009; 6 (5) . https://dx.doi.org/10.2174/1570180810906050374
DOI https://dx.doi.org/10.2174/1570180810906050374 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fish and Apoptosis: Molecules and Pathways
Current Pharmaceutical Design Metallopharmaceuticals in Therapy - A New Horizon for Scientific Research
Current Medicinal Chemistry Novel Antimicrobial Agents for the Management of Maxillofacial and Neck Infections
Recent Patents on Anti-Infective Drug Discovery Codon Swapping of Zinc Finger Nucleases Confers Expression in Primary Cells and <i>In Vivo</i> from a Single Lentiviral Vector
Current Gene Therapy Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations
Current Pharmaceutical Biotechnology Development and Clinical use of Prasugrel and Ticagrelor
Current Pharmaceutical Design The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy
Current Pharmaceutical Design Identifying Changes in the Synaptic Proteome of Cirrhotic Alcoholic Superior Frontal Gyrus
Current Neuropharmacology Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod
Current Drug Targets Patent Selections
Recent Patents on DNA & Gene Sequences Cellular Selenoprotein mRNA Tethering via Antisense Interactions with Ebola and HIV-1 mRNAs May Impact Host Selenium Biochemistry
Current Topics in Medicinal Chemistry STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry Bacterial Sepsis and Chemokines
Current Drug Targets Comparison of Pharmacokinetics of Cyclosporine A in Cadaveric and Living- Related Renal Transplant Recipients and in an Experimental Rat Model of Renal Failure
Drug Metabolism Letters Stability and Bioactivity Studies on Dipeptidyl Peptidase IV Resistant Glucogan-like Peptide-1 Analogues
Protein & Peptide Letters Syntheses, Urease Inhibition, and Antimicrobial Studies of Some Chiral 3-Substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles
Medicinal Chemistry Effects and Mechanism of Organ Protection by Cardiotrophin-1
Current Medicinal Chemistry Current Antiviral Therapy for Chronic Hepatitis C Including Liver Transplantation and Hepatic Resection
Current Medicinal Chemistry - Anti-Infective Agents Transdermal Innovations in Diabetes Management
Current Diabetes Reviews Natural Products on Nonalcoholic Fatty Liver Disease
Current Drug Targets